A robot named Nao (C) stands on the floor during a session with residents, at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)

A person living with Alzheimers disease uses a phone to speak to an AI chatbot called 'Livanna', at a care home for people with neurodegenerative diseases, in Septfonds on September 17, 2026. According to France-Alzheimer, around 1.4 million people are affected by this neurodegenerative disease, which severely impacts memory, cognitive functions and independence. At La Septfontoise, near Montauban, the telephone used by the care home is equipped with an AI system called Livana, which has been trialled for several weeks by seven of the 29 residents in the secure unit for people with Alzheimer's disease. (Photo by Ed JONES / AFP via Getty Images)

A carer hang a robot named Nao during a session, at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)

A carer programmes a robot named Nao (L) before a session with resident, at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)

A robot named "Miroki" (L), a carer (C) and residents attend a "robot session", at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)

A phone handset used by people living with Alzheimers disease to talk with an AI chatbot is displayed at a care home for people with neurodegenerative diseases, in Septfonds on September 17, 2026. According to France-Alzheimer, around 1.4 million people are affected by this neurodegenerative disease, which severely impacts memory, cognitive functions and independence. At La Septfontoise, near Montauban, the telephone used by the care home is equipped with an AI system called Livana, which has been trialled for several weeks by seven of the 29 residents in the secure unit for people with Alzheimer's disease. (Photo by Ed JONES / AFP via Getty Images)

A woman living with Alzheimers disease uses a phone to speak to an AI chatbot called 'Livanna', at a care home for people with neurodegenerative diseases, in Septfonds on September 17, 2026. According to France-Alzheimer, around 1.4 million people are affected by this neurodegenerative disease, which severely impacts memory, cognitive functions and independence. At La Septfontoise, near Montauban, the telephone used by the care home is equipped with an AI system called Livana, which has been trialled for several weeks by seven of the 29 residents in the secure unit for people with Alzheimer's disease. (Photo by Ed JONES / AFP via Getty Images)

A robot named Miroki looks on during a session with residents, at the Broca Hospital, on September 16, 2026, in Paris. The potential of AI to soothe patients and stimulate their cognitive functions is also being explored at the Broca Living Lab, an applied research laboratory run by the Assistance publique-Hôpitaux de Paris (AP-HP). (Photo by Lou BENOIST / AFP via Getty Images)